Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie I Fletcher

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Cancer Research|December 8, 2016
A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated CancersMoonSun Jung, Amanda J Russell, Bing Liu, et al.
Cancer Research|July 12, 2020
Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer ProgressionJixuan Gao, MoonSun Jung, Chelsea Mayoh, et al.
Science (New York, N.Y.)|February 10, 2007
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or BakSimon N Willis, Jamie I Fletcher, Thomas Kaufmann, et al.
Nature Communications|February 15, 2024
The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylationChristopher B Nelson, Samuel Rogers, Kaushik Roychoudhury, et al.
British Journal of Cancer|July 21, 2020
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcomaAshleigh M Fordham, Jinhan Xie, Andrew J Gifford, et al.
Oncogene|March 4, 2020
Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibitionAaminah Khan, Emanuele Valli, Hayley Lam, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
Journal of Medicinal Chemistry|November 18, 2025
Second-Generation AURKA-Targeting PROTACs: Structural Optimization toward in Vivo Degradation in NeuroblastomaSimon Krols, Muhammad Rishfi, Fien Martens, et al.
Cancer Research Communications|July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision TherapyNadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
British Journal of Cancer|September 2, 2021
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcomaVinod Vijay Subhash, Libby Huang, Alvin Kamili, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Cancer Research|December 8, 2016
A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated CancersMoonSun Jung, Amanda J Russell, Bing Liu, et al.
Cancer Research|July 12, 2020
Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer ProgressionJixuan Gao, MoonSun Jung, Chelsea Mayoh, et al.
Science (New York, N.Y.)|February 10, 2007
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or BakSimon N Willis, Jamie I Fletcher, Thomas Kaufmann, et al.
Nature Communications|February 15, 2024
The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylationChristopher B Nelson, Samuel Rogers, Kaushik Roychoudhury, et al.
British Journal of Cancer|July 21, 2020
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcomaAshleigh M Fordham, Jinhan Xie, Andrew J Gifford, et al.
Oncogene|March 4, 2020
Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibitionAaminah Khan, Emanuele Valli, Hayley Lam, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
Journal of Medicinal Chemistry|November 18, 2025
Second-Generation AURKA-Targeting PROTACs: Structural Optimization toward in Vivo Degradation in NeuroblastomaSimon Krols, Muhammad Rishfi, Fien Martens, et al.
Cancer Research Communications|July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision TherapyNadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
British Journal of Cancer|September 2, 2021
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcomaVinod Vijay Subhash, Libby Huang, Alvin Kamili, et al.
Pageof 6